CanSino's Omicron mRNA shot reports 'positive' trial data

A Chinese patient receives a COVID shot (Credit: STR—AFP via Getty Images)

Over two years since the first mRNA vaccines were approved in the U.S., China may be inching closer to having its own mRNA shot.

Chinese pharmaceutical company CanSino Biologics said it was in a “test production phase” of its Omicron-targeting mRNA booster, in a social media post published Friday.